Skip to content
MarketScale
‹ Back to IndustriesSciences

Addressing the Lack of Diversity in STEM Careers

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · Diversity in StemEducationInstitutional BiasesMentorship
Share

Key takeaways

01

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases.

02

Early education programs often fail to expose them to technology career paths or inspire a love for technology.

03

The lack of role models within their circles discourages them from pursuing STEM careers and has…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

Minorities continue to face challenges in pursuing STEM careers due to a lack of access to resources and institutional biases. Early education programs often fail to expose them to technology career paths or inspire a love for technology. The lack of role models within their circles discourages them from pursuing STEM careers and has created a pressing need for addressing educational disparities in STEM for underserved youth.

Programs like Challenges and Opportunities for Minorities in STEM Jobs and All-In STEM, founded by Dr. Kenneth Gibbs Jr. and Dr. Ciara Sivels exist with the purpose of addressing educational disparities in STEM for Underserved Youth. The program offers hands-on experience and technical knowledge to students, as well as the opportunity to work in a STEM field of their interest. Olwyn DePutron, the Director of Step IT Up America at UST, another similar program, shares their opinion about providing a path for underrepresented minorities to enter and thrive in STEM careers, where a more diverse and inclusive future for the industry can be created.

Olwyn’s Thoughts:

“In today’s workplace, there’s still a limited number of minorities pursuing STEM careers. The reasons behind this falls into a few buckets. One reason is that in the early education age, there are not a lot of programs available within the schools minorities attend to expose them to the different technology career paths or even to help them to build a love for things technology-wise in addition to the early education.

The familiar circles or relationship circles that minorities grow up in and the individuals they encounter often have jobs outside of technology. There’s often not a role model who would encourage them to pursue STEM careers or to pursue them to build skill sets for STEM careers.

Lastly, the opportunities afforded to them are often done so without the education, without the mentorship, and without guidance. They would not be directed to STEM fields or STEM careers. The Step Up program gives them the education, it gives them the mentorship, and it also gives them an opportunity, an open door to start off that career in technology.

The program allows them to pursue a passion that they may have for technology and train them up in a skillset. From the beginning, all the way to giving them hands-on experience, technical knowledge, and an opportunity to work in a field or in a specific role where they can enhance and build upon the skillset that they learned in the classroom.

In addition, they’re mentored not only by a coach but also a mentor who is within the client organization. Lastly, the client in partnership with us affords them an opportunity to get a role within that organization and continue to build up on their skillset and continue to move forward in a technology field of their interest.”

Article by Galina Mikova.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech’s $750M Hillsboro build adds device fill-finish capacity by 2031

Genentech is investing $750 million in a new fill-finish plant in Hillsboro. The facility will focus on the production of prefilled syringes and autoinjectors. The site is expected to become operational in 2031.

  • 01Genentech is investing $750 million in a new Hillsboro facility.
  • 02The facility will produce prefilled syringes and autoinjectors.
  • 03Operations at the plant are expected to begin in 2031.

Aug 27, 2026

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio hpDNA in Genezen projects could cut AAV input DNA by 30%

4basebio's cell-free hpDNA will be used by Genezen as starting material for viral vectors, potentially reducing the need for AAV input DNA by 30%. This innovation may lead to changes in the specification of plasmids and project timelines in gene therapy programs.

  • 01Genezen will utilize 4basebio’s cell-free hpDNA for viral vector production.
  • 02This approach could reduce AAV input DNA requirements by 30%.
  • 03The adoption of hpDNA could lead to changes in plasmid specification and project timelines.

Aug 27, 2026

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers has terminated its agreement with Cellares, which raises concerns about the standardized capacity for cell therapy production. This decision highlights the importance of aligning manufacturing processes with production capabilities, rather than merely focusing on the availability of factory slots.

  • 01Bristol Myers has terminated its agreement with Cellares, affecting cell therapy capacity.
  • 02Aligning process fit with production capabilities is crucial for cell therapy success.
  • 03Factory slots alone are not sufficient to ensure supply plans in cell therapy production.

Aug 26, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512